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Abstract
Staphylococcus aureus is a highly virulent and successful pathogen that causes a
diverse array of diseases. Recently, an increase of severe infections in healthy
subjects has been observed, caused by community-associated methicillin-resistant
S. aureus (CA-MRSA). The reason for enhanced CA-MRSA virulence is unclear;
however, work suggests that it results from hypersecretion of agr-regulated toxins,
including secreted proteases. In this study, we explore the contribution of
exo-proteases to CA-MRSA pathogenesis using a mutant lacking all 10 enzymes.
We show that they are required for growth in peptide-rich environments, serum,
in the presence of antimicrobial peptides (AMPs), and in human blood. We also
reveal that extracellular proteases are important for resisting phagocytosis by
human leukocytes. Using murine infection models, we reveal contrasting roles for
the proteases in morbidity and mortality. Upon exo-protease deletion, we
observed decreases in abscess formation, and impairment during organ invasion.
In contrast, we observed hypervirulence of the protease-null strain in the context
of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo-proteases to be key mediators of virulence-determinant stability. Specifically, increased abundance of both secreted (e.g. a-toxin, Psms, LukAB, LukE,
PVL, Sbi, c-hemolysin) and surface-associated (e.g. ClfA+B, FnbA+B, IsdA, Spa)
proteins was observed upon protease deletion. Collectively, our findings provide a
unique insight into the progression of CA-MRSA infections, and the role of
secreted proteolytic enzymes.

Introduction
Staphylococcus aureus is a highly successful and diverse
pathogen causing an array of diseases. S. aureus infections
typically proceed from localized sites (e.g. wound), and
can proliferate via bacteremia to life-threatening systemic
diseases, such as osteomyelitis, endocarditis, and septic
arthritis. This diversity and pathogenic success can be
attributed, largely, to its vast array of temporally and
environmentally regulated virulence factors (Lowy 1998;
Novick 2006). Formerly, S. aureus infections were confined to healthcare settings, afflicting the immunocompromised and elderly. Recently, there has been a shift in
S. aureus epidemiology, with increased incidences of
18

severe invasive disease in healthy subjects lacking
predisposing factors (Moran et al. 2006; Johnson et al.
2007). This trendshift is the result of emerging, hypervirulent strains of methicillin-resistant S. aureus (MRSA)
that have evolved within the community (CA-MRSA). Of
considerable concern, these CA-MRSA strains appear to
be moving into clinical settings and displacing existing
hospital-associated MRSA isolates (Popovich et al. 2008;
D’Agata et al. 2009; Webb et al. 2009).
Several CA-MRSA lineages have appeared in the last
decade (McDougal et al. 2003; Diep and Otto 2008; Limbago et al. 2009), with USA300 now representing the
major clone in the U.S. (Tenover et al. 2008). The reason
for the surprising success of this strain as the primary
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CA-MRSA, and perhaps MRSA, isolate is somewhat
unclear; however, work by a number of groups suggests it
may be attributable to the differential expression of core
genomic elements (Li et al. 2009), including the PSMs,
hemolysins, enterotoxins, and extracellular proteases
(Adem et al. 2005; Wang et al. 2007; Diep and Otto
2008; Montgomery et al. 2008; Kobayashi and DeLeo
2009; Li et al. 2009). With regards to this latter class of
enzymes, S. aureus possesses 10 major secreted proteolytic
enzymes. These include a metalloprotease (aureolysin,
aur), a V8 or SspA serine protease, two cysteine proteases
(staphopain A (ScpA) and staphopain B (SspB)), and six
serine-like proteases that are SspA homologues (SplABCDEF) (Reed et al. 2001; Shaw et al. 2004).
A number of studies have been conducted to determine
the contribution of extracellular proteases to the disease
process; however, many have been contradictory. In the
RN6390 background, an SspA mutant displayed attenuated virulence in three different animal models of infection (Coulter et al. 1998). Similarly, sspABC and sspBC
mutations in strain 8325-4 also showed reduced virulence
in a murine skin abscess model (Shaw et al. 2004). In
addition to these findings, it has been shown that both
cysteine proteases induce vascular leakage and shock in a
guinea pig model of infection (Imamura et al. 2005). Furthermore, it was shown that the ability of Newman to
evade killing by primary human macrophages is dependent on a functional aureolysin gene (Burlak et al. 2007;
Kubica et al. 2008). Finally, a number of studies have
shown that Aur, SspA, and SspB are produced upon
engulfment by human neutrophils, and that antibodies
are generated against these enzymes during infection
(Burlak et al. 2007; Calander et al. 2008; Holtfreter et al.
2009). In contrast, several other studies have produced
opposing results regarding the pathogenic role of extracellular proteases. Specifically, single mutations in aur and
scpAB using strain 8325-4 had no effect on skin abscess
formation (Shaw et al. 2004), whereas a nonpolar sspA
mutant in RN6390 displayed enhanced virulence in a
similar model (Rice et al. 2001). Additionally, mutants in
sspABC, sspB, aur, and scpAB, in the SH1000 background
produced no attenuation in virulence in a murine-septic
arthritis model (Calander et al. 2004). It was also
observed that a splABCDEF deletion mutant showed no
significant difference in virulence in a murine peritonitis
infection model (Reed et al. 2001).
In addition to these more general functions, S. aureus
exoproteases have been shown to cleave specific host proteins. Staphopain B can degrade human fibronectin,
fibrinogen, and kininogen, and may contribute to the
ability of S. aureus to disseminate (Massimi et al. 2002;
Imamura et al. 2005). Secreted proteases can also cleave
human a1-proteinase inhibitor (Potempa et al. 1986), the
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heavy chains of all human immunoglobulin classes (Prokesova et al. 1992), and elastin (Potempa et al. 1988),
which aids in tissue invasion. Beyond their interaction
with the host, it has been demonstrated that secreted proteases modulate the stability of self-derived virulence
determinants. Specifically, SspA was shown to cleave surface proteins, including fibrinogen-binding protein
(McGavin et al. 1997) and surface protein A (Karlsson
et al. 2001). In addition, Aur cleaves the surface-associated
protein clumping factor B (McAleese et al. 2001).
Cleavage of these proteins by extracellular proteases is
thought to affect the transition from an adhesive to an
invasive phenotype. It has also been suggested that extracellular proteases can cleave secreted toxins in order to
regulate the abundance of virulence factors depending on
the specific niche encountered within the host (Lindsay
and Foster 1999). Indeed, it has recently shown that aureolysin modulates the stability of both a-toxin and phenolsoluble modulins in CA-MRSA strains (Zielinska et al.
2011; Gonzalez et al. 2012).
Consequently, while there is a wealth of information on
the role of secreted proteases in S. aureus disease causation, the specific role of these enzymes as virulence factors
remains unclear. Therefore, in this study, we sought to
define the collective impact of this class of enzymes on
pathogenesis and virulence-determinant stability. This was
achieved using the CA-MRSA strain USA300, which is
known to hyperproduce secreted proteases, and a strain
genetically lacking all 10 of these enzymes.

Experimental Procedures
Bacterial strains, plasmids, and growth
conditions
The CA-MRSA USA300 LAC isolate AH1263 served as
the wild-type strain for analysis in this study. A derivative
of this has been generated and described previously
(Wormann et al. 2011) that lacks all 10 major secreted
proteases (strain AH1919). This was generated as follows:
Plasmids for the silent deletion of sspAB and scpA were
prepared using the pKOR1 derivative, pJB38 (Wormann
et al. 2011). Next, a USA300 LAC aureolysin mutant was
generated using a previously made pKOR1::aur silent-deletion
construct (Kavanaugh et al. 2007). Once confirmed, this
strain was used for the subsequent inactivation of sspAB,
followed by scpA, using the pJB38 plasmids referred
to above, and a protocol established for pKOR1 gene
inactivation (Bae and Schneewind 2006). Finally, an existing DsplABCDEF::erm (Dspl::erm) mutation (Reed et al.
2001) was transduced into this strain using bacteriophage
80a to create a LAC DaurDsspAB DscpA Dspl::erm total
exoprotease deletion strain.
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Strains were grown in TSB as documented (Shaw
et al. 2008), using the following protocol: 1 mL of
overnight S. aureus cultures were used to inoculate fresh
medium and allowed to grow for 3 h. These exponentially growing cultures were used to seed new medium
at an OD600 of 0.05. These exponentially growing test
cultures were then allowed to grow for the necessary
time periods. Growth in milk broth was performed as
previously described (Carroll et al. 2012). Briefly, exponentially growing cultures of the LAC wild-type and
protease-null strain were washed three times with PBS
and resuspended in 100 mL 10% skimmed milk. The
initial inoculum of each strain was also determined at
this time by serial dilution and plating on TSA. Cultures
were incubated at 37°C with shaking and the cfu/mL of
each strain determined at the times indicated, again by
serial dilution and plating. For growth in pig serum,
exponentially growing cultures of the LAC wild-type and
protease-null strain were washed three times with PBS
and resuspended in 1 mL of pig serum (Sigma). In each
case, approximately 1 9 106 cfu/mL of exponentially
growing cells were inoculated for each strain. Cultures
were incubated at 37°C with shaking and the cfu/mL of
each strain determined by serial dilution and plating,
every hour for 5 h. The initial inoculum of each strain
was also determined from the original culture in the
same manner. Data are presented as percentage survival
of each strain compared with initial inocula. All growth
experiments represent at least three independent biological replicates. Statistical significance was evaluated using
a Student’s t-test.

Real-time PCR
Quantitative real-time PCR analysis was conducted as
described previously (Miller et al. 2012) using primers
specific for RNAII (F- ATGCGCTGATGATATACCACG,
R- GTTGATAGACCTAAACCACGACC), RNAIII (F- AT
TTGTTCACTGTGTCGATAATCC, R- GGAGTGATTTCA
ATGGCACAAG), and hla 7(F- CGAAAGGTACCATTGC
TGGTCAGT, R - AAATGCTGAAGGCCAGGCTAAACC).
The control primers were for the 16s rRNA gene, as
described elsewhere (Koprivnjak et al. 2006).

Whole human blood survival assay
Survival in whole human blood was performed as previously
described (Kolar et al. 2011). In each case, approximately
1 9 106 cfu/mL of exponentially growing cells were inoculated for each strain. These experiments were performed with
three separate, deidentified blood samples (purchased from
Bioreclamation) and represent nine independent biological
replicates. Data are presented as percentage survival of each

20

strain compared with initial inocula. Statistical significance
was evaluated using a Student’s t-test.

Rabbit blood assay for a-hemolysin activity
Detection of a-hemolysin activity was performed using rabbit blood (Lampire Biological Laboratories, Pipersville,
PA), as described previously (Lindsay and Foster 1999).

Flow cytometry analysis
Phagocytosis of the wild-type and protease-null mutant
was analyzed using pooled, whole human blood coupled
with flow cytometry. Briefly, a constitutively expressing
GFP plasmid (pOS1sGFP::PsarA, Dr Victor J. Torres, gift)
was transduced into both strains using phage Φ11, and
confirmed by PCR analysis. Strains were then used to
infect human blood as described above, before being incubated at 37°C for 4h. After this time, aliquots were
removed and APC anti-CD4 and PerCP anti-CD45 antibodies (Becton Dickinson, Franklin Lakes, NJ) were added.
These were incubated on ice for 10 min to allow interaction, before erythrocytes were lysed by the addition of
RBC buffer (155 mmol/L NH4Cl, 100 mmol/L NaHCO3,
100 lmol/L EDTA) for 10 min at room temperature.
White blood cells were separated by centrifugation at
500 9 g for 5 min, and cells fixed using 1% formaldehyde
solution in 1 9 PBS. Cells were then stained with DAPI to
ensure that only nuclei-bearing cells were analyzed, and
not residual, lysed, RBCs. Cells were then separated
according to size, granulocity, antibody staining, and GFP
fluorescence using forward and side scattering in an FACs
Excalibur cytometer (BD Biosciences, Franklin Lakes, NJ).
FACs Diva version 6.1.3 software was used to gate cells
and analyze the subsequent data produced. Results represent an average of three independent biological replicates,
and are presented as number of GFP-positive cells  SEM.

Antimicrobial peptide-sensitivity assay
Liquid cultures of LAC and its protease-null mutant were
grown in Luria–Bertani (LB) media without NaCl. These
were diluted 1:1000 in fresh LB, again lacking NaCl, and
200 lL was applied to the wells of a 96-well plate. In each
case, approximately 1 9 106 cfu/mL of exponentially
growing cells were inoculated for each strain. The antimicrobial peptides (AMPs) LL-37, Indolicidin or Histatin-5
were added to these wells in decreasing concentrations
and mixed by pipetting. Plates were incubated at 37°C
overnight, followed by the measurement of culture density by OD600 readings. Data are presented as percentage
of inoculum, which was determined by comparing overnight OD600 values to no drug controls for each strain.
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All experiments represent at least three independent biological replicates. Statistical significance was evaluated
using a Student’s t-test.

Murine model of skin abscess formation
All animal studies in this work were performed in accordance with and approved by, the Institutional Animal
Care and Use Committee of the University of South
Florida (Permit Number: A-4100-01). For the skin abscess
model, experiments were conducted as described previously (Bunce et al. 1992; Shaw et al. 2004). Briefly,
6-week-old, female SKH1-E nude mice were purchased
from Charles River Laboratories, and housed at the
vivarium in the College of Medicine, University of South
Florida. S. aureus strains LAC and LAC-protease null were
grown for 15 h in TSB as described above. After this
time, aliquots of these bacterial suspensions were stored
at 80°C, and their cfu/mL determined retroactively by
serial dilution and viable cell counts. For infection purposes, cultures were thawed, washed twice in PBS, and
diluted in PBS containing 20 lg of sterile Cytodex microcarrier beads to 5 9 108 cfu/mL. Ten mice per strain
were inoculated subcutaneously between the scapula with
200 ll bacterial suspension, giving a final inocula of
1 9 108 cfu/mL. Mice were monitored for 6 days during
the infectious process, before being sacrificed, and any
abscesses harvested and stored at 80°C. Each abscess
was subsequently homogenized in 3 mL sterile PBS, and
the cfu/abscess determined via serial dilution and viable
count enumeration. Statistical significance was evaluated
using a Student’s t-test.

Murine model of sepsis and dissemination
These experiments were conducted as described previously (Voyich et al. 2006; Li et al. 2009). Briefly, 6-weekold, female CD-1 Swiss mice were purchased from
Charles River Laboratories, and housed at the vivarium
in the College of Medicine, University of South Florida.
S. aureus strains LAC and LAC-protease null were prepared as for the skin abscess model. For infection
purposes, cultures were thawed, washed twice in PBS,
and diluted in PBS to 1 9 109 cfu/mL. Thirty mice per
strain were inoculated by tail vein injection with 100 lL
bacterial suspension, giving a final inocula of
1 9 108 cfu/mL. The infection was allowed to proceed
for 6 days, or until mice reached a premoribund state
(used as a measure of mortality). Mice were then euthanized and the brain, liver, kidneys, heart, lungs, and
spleens collected and stored at 80°C. Any mouse sacrificed before day 6 was recorded for mortality, but their
organs were not analyzed for bacterial burden. Each

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

Proteases and Virulence

organ was subsequently homogenized in 3 mL sterile
PBS, and the cfu/organ determined via serial dilution and
viable count enumeration. The statistical significance of
bacterial recovery was evaluated using a Mann–Whitney
Test; mortality was measured using a log rank and chisquared test with 1-degree of freedom.

Proteomic analysis of surface and secreted
proteins
Stationary phase (15 h) cultures of wild-type and mutant
strains were prepared in TSB, and their secretomes were
harvested and purified as described previously (Rivera
et al. 2012). Surface proteins were extracted by methods
previously described (Gatlin et al. 2006). Briefly, wild-type
and LAC-protease-null mutant cells were grown to stationary phase (15 h) and sedimented via centrifugation. Pellets
were resuspended in TSM buffer (100 mmol/L Tris-HCl,
500 mmol/L sucrose, 10 mmol/L MgCl2) and incubated in
the presence of 100 lg of lysostaphin for 60 min at 37°C.
Supernatants were collected and precipitated with 10% trichloroacetic acid, followed by centrifugation to recover
precipitates. These were then washed thrice with 100% icecold ethanol, before being air-dried. Triplicate samples of
secreted and surface proteins for each strain were resuspended in urea buffer, with 15 lg/mL loaded and run on
12% SDS-PAGE gels. At least two lanes were left between
each sample to prevent loading contamination, with wildtype and mutant strains run on separate gels. Following
this, secreted protein gels were cut into 11 approximately
equal fractions, while surface proteins gels were separated
into 10 approximately equal fractions. These were then
washed with ACN to remove SDS and bromophenol blue,
before being dried using a SpeedVac centrifuge (Labconco,
Kansas City, MO). Gel pieces were rehydrated with 100 lL
of 45 mmol/L DTT and incubated at 55°C for 30 min.
The supernatant was removed and replaced with
100 mmol/L iodoacetamide and incubated in the dark at
room temperature for 30 min. Following this, the buffer
was removed and washed thrice with 50% ACN/50 mmol/L
ABC with agitation for 15 min. Gel pieces were dried
again using a SpeedVac centrifuge. Promega Trypsin
(12.5 ng/lL) was dissolved in Promega trypsin buffer, and
enough trypsin solution was used to cover the gel pieces,
before incubation at 37°C for 12–16 h. The supernatant
was removed and retained, and the reaction stopped with
5% glacial acetic acid. The gel pieces were covered with
100 lL of 50:50 ACN:water containing 0.1% formic acid
and vortexed for 15 min. Supernatants were again
removed and added to the previously collected supernatants. Samples were dried using a SpeedVac centrifuge, and
resuspended in 1 mL of 0.1% formic acid in water. Samples were then desalted and analyzed using a linear ion
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trap-LTQ instrument mass spectrometer (LTQ XL,
Thermo, Waltham, MA) operated using Xcalibur (v2.0.7,
Thermo Fisher Scientific, Waltham, MA) data acquisition
software, as described by us previously (Rivera et al. 2012).

Western blotting
Secretome and surfactome samples were prepared as
described for the proteomics studies. Samples were standardized to equal protein concentrations and probed
using antibodies specific for PVL-LukS (IBT Bioservices,
Gaithersburg, MD), Spa (Mark Smeltzer, gift), and SasG
(AB Chem, Dorval, Quebec, Canada), as described previously (Shaw et al. 2004). Images are representative from
more than three independent biological replicates.

Statistical analyses
All statistical analyses in this study were performed using
SAS software (version 9.2; SAS Institute, Cary, NC). The
distribution of data was determined in SAS through
tests for normality (SAS proc univariate) and equality of
variance (SAS proc ttest). For parametrically distributed
data, a Student’s t-test was used. The statistical significance of bacterial recovery from the murine model of
sepsis was evaluated using a Mann–Whitney test. Mortality was measured using a log rank and chi-squared test
with 1-degree of freedom. For all statistical analyses, the
significance level was set at a = 0.05.

Results
Verification of extracellular protease
depletion in the LAC-protease-null strain
An extracellular protease-null strain of S. aureus has
previously been generated and described in USA300 LAC
(Wormann et al. 2011). As it forms the basis of the
work described herein, we first set out to confirm the lack
of secreted proteases in this strain using a targeted proteomics method. Targeted mass spectrometry uses the
inclusion of mass-to-charge ratios in order to guide MS
sequencing to a predetermined subset of peptides, and is
more accurate than other methods that overlook certain
proteins. The Aur, SspA, SspB, ScpA, and SplA (used as a
representative for the spl operon) sequences were analyzed
using the Protein Prospector-MS digest program to determine peptides that would result after trypsin digest.
A peptide that is unique to each protease was chosen,
and its mass-to-charge ratio included in a designed MS
method. Overnight secretome samples (15 h) from the
LAC wild type and LAC-protease-null mutant were prepared and analyzed using an LTQ-MS. Spectral counts of

22

S. L. Kolar et al.

proteins identified were compared with the LAC wild
type producing robust counts for SspA (48), ScpA (49),
SspB (50), Aur (47), and SplA (8). As expected, when the
LAC-protease-null mutant secretome was probed, no
extracellular proteases were detected. This finding was
also verified via gelatin zymogram, with the LAC wild
type producing several activity bands, whereas the mutant
displayed none (Fig. S1). To ensure that no additional,
unintended mutations (specifically agr) had occurred in
the LAC-protease-null strain, we also performed real-time
PCR analysis with primers specific to RNAII, RNAIII,
and hla, with the latter serving as a representative agrregulated virulence determinant. We found that, at both
5 h and 15 h of growth, there was no observable different
between the two strains in the levels of these transcripts
(Fig. S2). As such, these analyses verify that an exoprotease-null strain of LAC was created that seemingly bears
no apparent additional mutations that impact the synthesis of virulence determinants.

The protease-null strain has fitness defects
during growth in peptide media and serum
We first sought to assess whether loss of extracellular proteases affected viability of the USA300 LAC strain. As
such, growth profiling was performed in complex media
(TSB) over a 96-h period, with no difference observed
compared to the parental strain (Fig. 1A). Additionally,
when using chemically defined media containing only
glucose and free amino acids as nutritive sources, we also
saw no alterations in growth between the strains (data not
shown). These findings are perhaps to be expected, as, for
example, agr mutants of S. aureus are aproteolytic, yet are
undoubtedly viable in complex media. Following this, we
next tested the ability of the protease-null strain to grow
in peptide-based media. This was performed as many bacterial species possess a PrtP homolog, which is a surfaceexposed protease that functions to generate oligopeptides
from polypeptides for nutrition (Siezen 1999; Liu et al.
2010). Such a protein is lacking in S. aureus (our unpublished observation), and therefore we reasoned that the
extracellular proteases perhaps fulfill such a function.
Accordingly, we grew the LAC parental strain and its
protease-null mutant in 10% milk broth (Fig. 1B), which
is routinely used to evaluate peptide-based nutrition
(Borezee-Durant et al. 2009), as it contains few free amino
acids, and abundant peptides. During the first 24 h of
profiling, no difference in viability for the LAC wild-type
and its protease-mutant strain was observed. Interestingly,
after this time, both strains began to lose viability, with
the protease-null strain proving significantly less able to
resist starvation compared with the parent. Specifically, by
day 2, the protease mutant produced a 2.3-fold decrease
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Figure 1. Secreted proteases aid in survival during growth in peptide-based media and serum. The average cfu/mL of the LAC wild type (●) and
LAC-protease-null mutant (■) were compared over 4 days in: (A) TSB and (B) 10% milk broth. (C) The average cfu/mL of the LAC wild type
(black) and LAC-ESPN mutant (gray) were compared at the times indicated during growth in pig serum. Data are expressed as percent recovery of
the inoculum. Presented is the average data from three independent biological replicates. In all cases, a Student’s t-test was used to determine
statistical significance, *P = 0.05, **P = 0.01, ***P = 0.005. Error bars are shown SEM.

in average cfu/mL, which was exacerbated at day 3 with a
fourfold decrease in survival. By day 4, a 3.1-fold decrease
in mutant viability was determined.
We next set out to assess the fitness of the wild type and
protease mutant during growth in a more pathogenically
relevant medium, in this case pig serum. Pig serum was
chosen due to ease of availability, and because it effects
have been shown previously to closely mimic those of
human serum (Wiltshire and Foster 2001). Accordingly,
exponentially growing cells of the parent and mutant were
inoculated into pig serum, and the survivability of three
biological replicate samples determined (Fig. 1C). When
growth was analyzed during early time points, a large
decrease in the viability of the protease null strain was
observed. Specifically, after 1 h, a 3.2-fold decrease in
mutant cell viability was observed (24.6% of the inoculum), compared with the parent strain (80.9% of the
inoculum). Viability stabilized after this time, yet still
produced a consistent twofold reduction in the mutant
strain compared to the parent from 2 to 5 h. After 24 h
of incubation, while both strains had robust growth
(Wt = 480.8% recovery of inoculum, protease-null
strain = 355.6%), there was still a decrease in final loads
of the mutant strain. This suggests that secreted proteases
may have a role in nutrition acquisition in S. aureus,
particularly during times of stress and starvation.

Secreted proteases play a role in resistance
to antimicrobial peptides
The specific mechanism by which the reduced viability of
the protease-null strain in serum is mediated is unclear.
Serum contains a number of antibacterial components that
may contribute to this growth defect, including complement. However, as there are no cell-mediated components
of the immune system within serum, complement would
not kill S. aureus cells in these assays. More likely, the
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decreased viability of the mutant strain is explained by the
fact that serum also contains abundant AMPs. In support
of this, it has previously been shown that the S. aureussecreted protease, aureolysin, is able to cleave the human
cathelicidin, LL-37 (Sieprawska-Lupa et al. 2004). To
determine if secreted proteases facilitate resistance to only
this AMP, or other such peptides, sensitivity profiling of
the mutant was performed (Fig. 2). While both strains
exhibited declining viability at increasing concentrations of
the AMP LL-37 (compared with their no-drug controls),
the protease-null strain was considerably more impaired.
Specifically, we observed a twofold decrease in proteasenull cells compared with the parental strain at a concentration of 45 lg/mL, which increased to >fourfold at 65 lg/
mL, and more than 7.5-fold at 85 lg/mL. Similar findings
were observed with indolicidin, with a 2.5-fold decrease in
viability observed for the mutant strain at 4 lg/mL, a more
than sevenfold observed at 6 lg/mL, and >10-fold at 7 lg/
mL. Finally, when these analyses were performed using
histatin-5 we observed a >2.5-fold decrease in mutant viability at 3 lg/mL, a >8.5-fold at 5 lg/mL, and >11-fold at
6 lg/mL. Collectively, it is apparent that extracellular protease deletion results in heightened sensitivity of S. aureus
cells to the effects of antimicrobial peptides; and that this
observation is not limited to a single peptide example. As
such, these findings strongly suggest that secreted proteases
are a major mechanism by which S. aureus resists the toxic
effects of AMPs.

Extracellular proteases are required for
survival during interaction with the innate
immune system
The in vitro AMP sensitivity assays suggest that extracellular proteases are important for survival during interaction with elements of the immune system. Accordingly,
we next profiled survivability of the mutant strain in
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Figure 2. Secreted proteases play a role in the resistance of S. aureus to antimicrobial peptides. The LAC wild type (●) and protease-null mutant
(■) were cultured with either LL-37, indolicidin or histatin-5. Values represent percentage of overnight OD600 readings for each concentration
compared with a no-drug control for each strain. Data presented is from at least three independent biological replicates. In all cases, a Student’s
t-test was used to determine statistical significance, with every point other than the first LL-37 concentration proving to be a minimum of
P = 0.05, with most being in excess of P = 0.001. Error bars are shown SEM.

the presence of the innate immune system, including its
cellular components. As such, exponentially growing LAC
wild-type and protease-null mutant cells were separately
cultured in whole human blood for 4 h, and their viability determined (Fig. 3). Analysis revealed that the LAC
wild type had bacterial loads that decreased only marginally from the initial inoculum (82.1% recovered). In contrast, the protease-null mutant displayed significantly
impaired survival, returning only 12.6% of the inoculum.
This results in a 6.5-fold reduction in survivability of the
mutant strain when compared with the parent. To understand the reason for this decline, we next analyzed phagocytosis of the two strains during infection in whole
human blood using flow cytometry. This was achieved
using variants of these two strains bearing a plasmid that
constitutively expresses gfp. These strains were incubated
under identical conditions to the whole human blood
survival assay, before white blood cells were isolated and
subjected to separation and analysis by FACS (Fig. 3).
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Importantly, when looking at all leukocytes collectively,
we observed an approximate twofold increase in the number of protease-null mutant cells that had been phagocytosed, when compared with the parental strain. When
performing more detailed analyses for specific cell types,
we again saw an equivalent twofold increase in proteasenull cells within both granulocytes and monocytes. Interestingly, when analyzing lymphocytes, we did not see a
meaningful or statistically significant fold change for the
mutant compared to the parental strain. Ultimately, these
data strongly suggest that secreted proteases play a key
role in protecting S. aureus during interaction with the
human immune system.

Monocytes

Figure 3. Secreted proteases are protective during interaction with the human innate immune system. The LAC wild-type and protease-null
strain were separately cultured in whole human blood for 4 h, before their viability was determined. Data is expressed as percent recovery of the
inoculum, and represents three separate blood samples and nine individual biological replicates. The phagocytosis of these strains in whole human
blood was also measured by FACs analysis using GFP-labeled variants grown in an identical manner. Data are expressed as number of GFP+ cells
for the mutant and wild type in the various types of white blood cell. Numbers are derived from three biological replicates. Error bars are shown
SEM. Statistical significance was calculated using a Student’s t-test, *P = 0.05, ***P = 0.005, ****P = 0.001.
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Reed et al. 2001; Rice et al. 2001; Calander et al. 2004;
Shaw et al. 2004; Imamura et al. 2005). As such, we set out
to determine if the 10 major secreted proteases collectively
contribute to localized infection using a murine model of
skin abscess. Accordingly, 10 mice were subcutaneously
inoculated with either the LAC wild type or protease-null
mutant, and the infection was allowed to proceed for
6 days. Following this, all mice were euthanized, any
abscesses harvested, and the bacterial loads per abscess
determined (Fig. 4). We observed that the protease null
mutant had significantly reduced bacterial loads per
abscess when compared with the wild type. Specifically,
the average wild-type cfu/abscess was 57.7% of the inoculum, whereas for the mutant it was 28.1%, representing a
twofold decrease in bacterial burden.

Extracellular proteases play a key role
during systemic CA-MRSA infections
In addition to presenting as skin and soft tissue infections, CA-MRSA is also a major cause of bacteremia and
systemic disease. As such, we next set out to determine if
extracellular protease deletion impacts systemic CA-MRSA
infections. Accordingly, mice were inoculated via tail vein
injection with 1 9 108 cells of either the LAC wild type
or protease-null mutant. The infection was allowed to
proceed for 6 days, or until mice reached a premoribund
state (used as a measure of mortality). Mice were then
euthanized and the brain, liver, kidneys, heart, lungs, and
spleens collected. Any mouse sacrificed before day 6 was
recorded for mortality, but their organs were not analyzed
for bacterial burden. Following recovery, each organ was
homogenized, serial diluted, and plated to determine
bacterial load. Of the 30 LAC wild-type animals, two
died prior to day 6, yielding a mortality rate of 6.6%
(Fig. 5). In contrast, seven of the 30 inoculated with the
*

CFU/Abscess

108
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Figure 4. Secreted proteases contribute to CA-MRSA skin abscess
formation. The LAC wild type and protease-null mutant were used to
subcutaneously inoculated the scapula of 10 SKH-1 mice each, at
1 9 108 cells. After 6 days, abscesses were harvested and bacterial
loads determined via homogenization and serial dilution. The average
cfu/abscess returned is indicated by horizontal bars. A Student’s t-test
was used to determine statistical significance, *P = 0.05.
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Figure 5. Deletion of secreted proteases results in increased mortality
during systemic CA-MRSA infection. The LAC wild type and protease
mutant were inoculated via tail vein injection into 30 CD-1 mice each,
at 1 9 108 cells. The infection was allowed to proceed for 6 days, or
until mice reached a premoribund state (used as a measure of
mortality). A log rank and chi-squared test with 1-degree of freedom
were used to determine statistical significance (P = 0.067).

LAC-protease null mutant died, giving a 23.3% mortality
rate. This represents a 3.5-fold increase in mortality for
the protease-null strain compared with the parental
strain. Statistical analysis of this finding resulted in a
P-value = 0.067, which is just outside the range of statistical significance.
Conversely, when analyzing bacterial burden per organ
between the two groups, we observed significant decreases for
the mutant strain in the liver, lungs, heart, and spleen (Fig. 6).
Specifically, the largest fold change, 98.7, was observed in the
lungs, with the LAC wild type returning an average cfu/lungs
of 4.74 9 104 and the protease null mutant returning
4.80 9 102. Additionally, we observed a 7.4-fold decrease in
bacterial load in the liver of inoculated mice, with the wild
type producing an average cfu/liver of 4.32 9 105 and the
mutant 5.79 9 104. The heart produced a 5.7-fold decrease in
mutant bacterial cells, with LAC yielding 1.2 9 104 and the
protease mutant yielding 2.1 9 103. With regards to the
spleen, we observed 2.01 9 103 cfu/spleen for the parental
strain and 6.6 9 102 for the mutant, which is a threefold
decrease. Finally, in the brain we observed a 3.8-fold decrease
in the average cfu/brain for mutant-infected mice, however,
this was found to be outside the range of significance
(P = 0.079). Interestingly, there was no significant difference
between the two strains in their ability to infect the kidneys of
inoculated mice. The LAC wild type returned 5.57 9 107 cfu/
organ, whereas the protease-null mutant returned 5.87 9 107.
Collectively, these data suggest that secreted proteases play a
major role in the survival of S. aureus during in vivo infection.

Secreted proteases are primary effectors of
virulence-determinant stability
It has previously been proposed (McGavin et al. 1997;
Lindsay and Foster 1999; Karlsson et al. 2001; McAleese
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Figure 6. Secreted proteases are required for systemic dissemination during septic CA-MRSA infections. The LAC wild type and protease mutant
were inoculated via tail vein injection into 30 mice each, at 1 9 108 cells. After 6 days, all surviving mice were euthanized, and their organs
harvested for bacterial load derivation. A Mann–Whitney test was used to determine statistical significance. *P = 0.05, **P = 0.01,
****P = 0.001.

et al. 2001; Zielinska et al. 2011; Gonzalez et al. 2012)
that secreted proteases regulate the stability of self-derived
toxins. To determine if this is in fact the case, we assessed
the impact of secreted proteases on virulence-determinant
stability using proteomic techniques. Accordingly, stationaryphase secretomes (15 h) of the LAC wild type and
protease-null mutant were collected in triplicate and separated via SDS-PAGE. Each gel was then cut into 11 identical fractions to facilitate processing. The data from all
11 fractions were pooled and collectively analyzed for
alterations in protein abundance using spectral counts
(Table S1). In total, 19 known secreted proteins had
increased abundance of 1.5-fold or greater upon deletion
of extracellular proteases. The highest fold change was
seen for phenol-soluble modulin alpha 4, with a 4.2-fold
increase in the mutant. Other well-known virulence
determinants were also found to be more abundant in the
protease-null strain, including two Lipases (Geh = 3.8fold, SAUSA300_2603 = 2.5-fold), components of the
c-hemolysin (HlgA = 2.4-fold, HlgC = 2.1-fold), a-toxin
(twofold), leukotoxin LukE (twofold), and enterotoxin Q
(1.5-fold). Our analysis also revealed increased abundance
of certain proteins in the wild-type strain, including all 10
secreted proteases, as expected, along with catalase (ninefold), the CamS pheromone (twofold), and two putative
lipoproteins (SAUSA300_2403 = twofold, SAUSA300_
0411 = threefold).
A consideration with this pooled analysis is that a
protein may be processed by secreted proteases into
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potentially inactive fragments, as a result of endoproteolysis. As the protein is not completely degraded to free
amino acids, each of these fragments will be detected by
MS analysis; therefore one may not observe any fold
change in spectral counts, yet cleavage has rendered the
protein nonfunctional. As such, protein abundance was
next compared within individual fractions from the
SDS-PAGE gels. Spectral counts for a given protein were
only analyzed for the single fraction that would contain
its full-length protein, based on predicted molecular
weight. (Fig. 7 and Table S2). The 19 proteins identified
from the pooled sample all had decreased abundance in the
wild-type strain in their relative molecular weight fractions; in many cases to even greater degrees than in our
collective analysis. For example, we observed increased
abundance for Sbi (ninefold), alpha-toxin (8.8-fold), phenol-soluble modulin alpha 4 (fivefold), c-hemolysin
(HlgA = fourfold), and LukE (3.6-fold) upon deletion of
extracellular proteases using this method. Furthermore,
an additional five proteins that did not produce a significant fold change in the pooled samples were identified as
being altered in protein stability in the mutant strain.
These include the two components of the Panton-Valentine leukocidin (LukS = 2.4-fold, LukF = 1.5-fold), the
staphylococcal complement inhibitor (3.6-fold), enterotoxin K (twofold), and secretory antigen SsaA (twofold).
Following this, we also performed a similar analysis
for surface proteins between the two strains. The rationale for this is that existing evidence in the literature
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suggests secreted proteases can also target surfaceexposed proteins in S. aureus (McGavin et al. 1997; Karlsson et al. 2001; McAleese et al. 2001). As such, the
cells used to generate secretomes were harvested, and
their surface protein fraction isolated, before being processed in an identical SDS-PAGE-based fashion. When
performing a collective analysis of spectral counts for all
fractions, we observed 10 proteins with a 1.5-fold or
greater increase in the protease-null mutant (Table S3).
These include fibronectin-binding proteins A (fourfold)
and B (threefold), as well as fibrinogen-binding protein
(2.3-fold), clumping factor A (1.7-fold), and IsdA (1.6fold). We also performed specific fraction analysis as
detailed above to determine those proteins with altered
protein stability upon deletion of the extracellular proteases (Fig. 8 and Table S4). Specific analysis revealed that,
in addition to the 10 surface proteins identified from
pooled studies, a further seven had increased stability in
the protease mutant. These included immunodominant
staphylococcal antigens A (2.3-fold) and B (2.2-fold),
staphylocoagulase (twofold), immunoglobulin G-binding
protein A (Spa = 2.1-fold), elastin-binding protein (twofold), and a putative surface protein (SAUSA300
_0883 = 2.4-fold). We again observed a general increase
in protein abundance for the majority of proteins identified by fraction analysis when compared with the pooled
data. The most striking of which was clumping factor B,
which, upon fraction analysis was found at levels eightfold higher in the mutant.
In order to independently corroborate our findings
from these proteomics studies, we performed Western blot
analysis for selected secreted and surface-associated virulence factors. Identical 15-h secretome and surfactome
samples were prepared as described for the proteomics
studies, and separately probed for PVL-LukS, SasG, or
Spa. In each case (Fig. S3), we observed decreased accumulation of these proteins in the parental strain when
compared to the protease-null mutant. Furthermore, to
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Figure 7. Extracellular proteases modulate the stability of a wealth of known secreted virulence factors. The secretome of LAC and its proteasenull strain were collected and fractionated via SDS-PAGE. Known, full-length secreted proteins were analyzed and their spectral counts
determined. Shown are the ratios of abundance for each secreted protein in the wild type (black) compared to the mutant (gray).
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Figure 8. Extracellular proteases modulate the stability of a number
of surface-associated virulence factors. The surfactome of LAC and its
protease-null strain were collected and fractionated via SDS-PAGE.
Known, full-length surface proteins were analyzed and their spectral
counts determined. Shown are the ratios of abundance for each
surface protein in the wild type (black) compared to the mutant
(gray).

demonstrate that protease inactivation not only leads to
increase protein stability, but also biological activity,
we profiled the cytolytic activity of Hla toward rabbit
erythrocytes. As expected, we observed a significant
increase in a-hemolysin activity in the protease-null strain
compared with the wild type (Fig. S4). These findings
support our proteomic analyses, and are consistent with
nonproteomic findings from our previous works, showing
increased stability of a-toxin, and the psms, upon protease
disruption (Zielinska et al. 2011).

Discussion
Recent reports suggest that MRSA is now the leading
cause of infectious disease and death by a single agent in
the U.S. (Camargo and Gilmore 2008; Kobayashi and
DeLeo 2009). This pathogenic success can largely be
attributed to the meteoric increase in CA-MRSA infections in the last decade (Moran et al. 2006; Johnson et al.
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2007; Popovich et al. 2008; Webb et al. 2009). Although
several CA-MRSA lineages exist, USA300 is now thought
to account for more than 50% of all MRSA infections in
some regions (Thurlow et al. 2012). The reason for the
surprising success of USA300 is somewhat unclear; however, work by a number of groups suggests it may be
attributable to the differential expression of core genomic
elements (Li et al. 2009), including the PSMs, hemolysins,
extracellular proteases (Fig. S5), and enterotoxins (Wang
et al. 2007; Diep and Otto 2008; Montgomery et al.
2008; Li et al. 2009). A number of studies performed by
ourselves and others have investigated the contribution of
extracellular proteases to disease causation (Coulter et al.
1998; Reed et al. 2001; Rice et al. 2001; Karlsson and
Arvidson 2002; Sifri et al. 2003; Calander et al. 2004;
Shaw et al. 2004; Imamura et al. 2005; Kubica et al. 2008;
Prajsnar et al. 2008). Thus far, these data have proved
contradictory, perhaps as a result of using strains that
have varying proteolytic capabilities. Some backgrounds
used (e.g. RN6390) have limited clinical significance,
while other studies have focused only on individual protease mutations. This latter point is of particular importance as it has been shown in other highly proteolytic
bacteria that significant levels of functional redundancy
exist (Travis et al. 1995). For these reasons, and to
explore the role of this class of enzymes in CA-MRSA
pathogenesis, we have focused in this study on a total
exoprotease-null mutant of USA300 LAC.
Interestingly, while we show that the mutant strain is
viable in complex media, we did observe a survival defect
during extended culturing in peptide-based media. Previous reports have shown that S. aureus cells can only
import octapeptides or smaller for nutrition-based purposes (Hiron et al. 2007). Therefore, it is possible that the
extracellular proteases of S. aureus cleave large oligopeptides into smaller fragments for growth and nutrition.
Interestingly, the defect was only apparent after 24 h of
growth. Thus, it is possible that at earlier time points, the
major nutrient source is carbon, free amino acids, and oligopeptides with less than eight residues. Once these more
readily usable nutrients have been exhausted, the focus
would then shift to breaking down oligopeptides with
greater than nine residues. In support of this assertion,
others (Borezee-Durant et al. 2009) have suggested that
S. aureus grown in milk during earlier time points uses
simple energy sources such as sugars and free amino
acids, before switching to more complex oligopeptides
during later growth phases. In this scenario, any strain
lacking extracellular proteases would be limited in their
ability to generate smaller, importable peptides for nutrition during later growth phases, explaining the survival
defect observed. This contention is supported by the
observation that, unlike a variety of other organisms,
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S. aureus lacks a PrtP homolog, which serves to breakdown large oligopeptides for import and nutrition (Siezen
1999; Liu et al. 2010). We also observed fitness defects in
the protease-null strain during growth in the more pathogenically relevant pig serum, whose effects have previously
been shown to closely mimic those of human serum
(Wiltshire and Foster 2001). These findings are perhaps a
result of an inability to degrade proteins for nutritive
purposes. In support of this, others have shown that
nutrition defects become emphasized during growth in
serum (Beasley et al. 2009). Additionally, it has also been
shown that extracellular proteases are strongly upregulated
during the growth of S. aureus in serum (Oogai et al.
2011); further suggesting that they may be important for
survival under these conditions. Serum also contains
complement, which is a key mediator of the immune
response to bacterial infection within the host. However,
as there are no cell-mediated components of the immune
system within serum, complement would have no ability
to kill S. aureus cells in our assays. Therefore, despite
reports detailing the role of secreted proteases in complement evasion (Laarman et al. 2011); this would seemingly
have little to do with the survival defect observed. More
likely, the decreased viability of the mutant strain is
explained by the fact that serum contains abundant
AMPs.
This contention is corroborated by our observation that
the protease mutant strain is more sensitive to AMPs. It
has previously been shown that aureolysin cleaves the
cathelicidin AMP, LL-37 (Sieprawska-Lupa et al. 2004).
Herein, we show that extracellular proteases facilitate
resistance to agents other than LL-37, as we observed
increased sensitivity to both indolicidin and histatin-5.
During infection, AMPs bind to bacterial cells through
cationic interactions at the cell surface, and exhibit antibacterial activity through several mechanisms (Brogden
2005). Therefore, in S. aureus, one would hypothesize that
secreted proteases aid in immune evasion by preemptively
degrading these agents. We further investigated this assertion by evaluating survival in whole human blood. In
addition to complement and AMPs, whole human blood
also contains cellular components of immunity. When
such profiling was performed we also saw major survival
defects in the mutant strain. The immune components of
serum and blood are relatively similar, and thus the
decreases in survivability observed may result from a lack
of AMPs and complement system degradation in the
mutant strain. However, in serum at 4 h, the mutant produced a twofold decrease, while in blood, a 6.5-fold
decrease was observed at the same time.
To further understand these findings, we performed
FACS analyses using GFP-labeled variants of the wild-type
and protease-null strain grown in human blood. After 4 h
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of incubation we observed increased phagocytosis of
protease-null cells compared with the parental strain. This
is in keeping with work by others, which shows that
Staphopain B can cleave both CD11b and CD31, which
block the phagocytosis of S. aureus by neutrophils and
monocytes (Smagur et al. 2009a,b). Furthermore, recent
work has shown that Staphopain A also contributes to
immune evasion by cleaving the chemokine receptor
CXCR2 (Laarman et al. 2012). Additionally, aureolysin is
known to inhibit phagocytosis of S. aureus by neutrophils
via the cleavage of C3 (Laarman et al. 2011). Our group
has also shown that a functional aureolysin is required to
survive phagocytosis by human macrophages (Kubica
et al. 2008). Finally, a number of the secreted proteases
have been shown to cleave components of human blood,
such as prothrombin and pro-uPA, in order to facilitate
survival and proliferation (Wegrzynowicz et al. 1980;
Beaufort et al. 2008). Collectively, one hypothesizes that
the survival defect of the protease-null strain in human
blood results from a reduced capacity to evade the
action of AMPs, alongside increased phagocytosis by leukocytes, ultimately leading to enhanced killing within the
phagosome. Collectively, findings from the literature,
along with our data presented herein, strongly argue
that extracellular proteases play a protective and beneficial
role during interaction of S. aureus with the host immune
system.
We also observed significant influence of the secreted
proteases on in vivo pathogenesis. This was first studied
for localized infection, using a murine model of abscess
formation. Over the course of a 6-day period, we
observed an approximately twofold decrease in virulence
for the mutant strain. This decrease is perhaps not as
large as would be expected; previous work has shown that
8325-4 sspA and sspB mutants are more than threefold
impaired in virulence when using this same model (Shaw
et al. 2004). The reason why a complete protease-null
mutant would display less attenuation than single protease mutants is likely explained by the proteomics works
conducted in this study. We observe that upon deletion
of the secreted proteases, the stability of a large number
of key virulence factors increases significantly. As such, a
protease-null strain actually accumulates more toxins,
rather than less. This is particularly important in this
model, as key mediators of skin infections, such as
a-toxin and the PSMs, are more abundant upon protease
inactivation. Therefore, the observed twofold reduction is
actually quite surprising, given the increased prevalence of
abscess-enhancing toxins. As such, any observed decrease
at all upon protease deletion is a major finding, and
suggests that the loss of these enzymes, despite being
subverted by other abscess-impacting agents, influences
the ability of S. aureus to cause localized disease.
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When using systemic infection models, we observed
further, and profound alterations in virulence that were
far in excess of those seen for localized infections. Specifically, the mutant displayed significantly decreased bacterial loads in the lungs, liver, heart, and spleen. The
specific explanations for these findings, are likely complex
and multifactorial. However, it has previously been shown
that secreted proteases can cleave human a1-proteinase
inhibitor (Potempa et al. 1986), a1-antichymotrypsin, the
heavy chains of all human immunoglobulin classes (Prokesova et al. 1992), elastin (Potempa et al. 1988), fibrinogen, fibronectin, high-molecular-weight kinininigen, and
plasminogen (Wegrzynowicz et al. 1980; Potempa et al.
1986, 1988; Massimi et al. 2002; Imamura et al. 2005;
Beaufort et al. 2008). Cleavage of each of these host proteins aids in tissue invasion, and perhaps explains the
decrease in mutant cells in these organs. Furthermore, we
demonstrate in our proteomics studies that protease-null
mutant cells have increased decoration of their cell walls,
as higher levels of surface proteins were observed upon
deletion of proteolytic enzymes. Indeed, our preliminary
studies have shown that the protease-null strain is significantly more adhesive to surfaces coated with human proteins, including elastin (our unpublished observations).
This coupled with our findings that the protease mutant
strain is less resistant to AMPs, and has decreased survival
in both serum and whole blood, might begin to explain
this phenotype. As such, one would hypothesize that
upon inoculation into the blood, the protease-null strain
would immediately display decreased fitness for survival,
increased attachment, decreased dissemination and invasion, and an inability to cleave key host proteins for survival, evasion, and nutrition.
In stark contrast to this, we in fact observe increased
killing by the protease-null mutant when mortality was
used as a measure of infection. This finding is of primary
importance, and speaks strongly to a major role for the
secreted proteases in controlling, and tightly regulating
the infectious process. Herein, we show major increases
in virulence-determinant stability upon inactivation of
extracellular proteases. Specifically, we show that a-toxin,
c-hemolysin, PSMs, LukE, LukAB, PVL, and others are all
more abundant in the protease-null strain. Importantly,
each of these factors have been linked to increased
virulence and mortality during S. aureus infection (Morinaga et al. 2003; Bubeck Wardenburg et al. 2007; Labandeira-Rey et al. 2007; Wang et al. 2007; Loffler et al.
2010; Dumont et al. 2011). Furthermore, work by McAdow and coworkers has shown that bacterial agglutination
in blood, mediated by ClfA, Coa, and vWbp, is associated
with lethal outcomes of S. aureus septic infections in mice
(McAdow et al. 2011). As we see elevated stability of both
ClfA and Coa in the protease-null strain, this may further
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explain the elevated mortality observed. Thus, despite the
loss of extracellular proteases and their effects on the
host, other major virulence factors are more prevalent
and stable. We propose that in the absence of proteolytic
activity, these other virulence factors exist unchecked, and
therefore provide the potential for the aggressive progression of infection observed. Indeed, the overproduction of
PVL has frequently been linked to the rapid and increased
mortality associated with necrotizing pneumonia (Morgan
2005; Garnier et al. 2006). Such a scenario is supported
by reports on the role of the cysteine protease, SpeB,
from group A Streptococci (GAS). When levels of this
enzyme rise in GAS, the stability and abundance of other
virulence factors is reduced, leading to impairments in
invasion and virulence (Chatellier et al. 2000; Kansal et al.
2000, 2003).
A major consideration with each of our phenotypic and
growth-related studies is that the data presented may be
skewed by elevated aggregation of the protease-null strain.
It has previously been reported that secreted extracellular
proteases have been shown to cleave surface and adhesive
proteins by other groups (McGavin et al. 1997; Karlsson
et al. 2001; McAleese et al. 2001). Therefore it is reasonable to project that the protease-null strain may display
elevated clumping compared with the parental strain, as
we intimate above. As a large part of our experimental
design was dependent on accurate cfu/mL values, we performed prior analyses to ensure that our data was not
influenced by such aggregative behavior. We determined
that extended vortexing produced identical cfu/mL values
to cellular disruption via sonication for both strains in
every growth condition and animal model used (data not
shown). As such, all cfu/mL values reported herein are the
result of phenotypic variations, rather than increased
clumping of the protease-null strain.
Therefore, this presents a scenario where, in addition
to their own, independent virulence-affecting roles, the
secreted proteases exist as key check point enzymes to
control the severity and intensity of infection via modulating the stability of other toxins and virulence determinants. Indeed, one could suggest that the regulatory
control of secreted proteases by the agr system is no accident, but in fact evolutionary design. In such a scenario,
any enhancement of agr activity, such as that seen in
CA-MRSA strains, would lead to massive toxin production, and death of the host organism. As an opportunistic
pathogen, such rapid killing of the host by S. aureus is
counterintuitive to survival. Therefore, by tying the production of other toxins to extracellular protease expression and activity, one is presented with an inbuilt
mechanism to self-regulate the overtly harmful and often
lethal effects of secreted toxins on the host, thus tempering and controlling the pathogenic process.
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In summary, we demonstrate that the extracellular proteases of S. aureus play a variety of key roles in the virulence process. Specifically, they aid in protection against
the innate immune system, at both cell-dependent and
independent levels. They also strongly impact the progression of localized and systemic CA-MRSA infections.
Finally, and perhaps most importantly, they are key
mediators of secreted and cell wall-associated virulencedeterminant stability. Collectively our findings provide a
unique insight into the progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.

Acknowledgments
This study was supported in part by grants AI090350
(L. N. S.) and AI078921 (A. R. H.) from the National
Institute of Allergies and Infectious Diseases.

Conflict of Interest
None declared.
References
Adem, P. V., C. P. Montgomery, A. N. Husain, T. K.
Koogler, V. Arangelovich, M. Humilier, et al. 2005.
Staphylococcus aureus sepsis and the WaterhouseFriderichsen syndrome in children. N. Engl. J. Med.
353:1245–1251.
Bae, T., and O. Schneewind. 2006. Allelic replacement in
Staphylococcus aureus with inducible counter-selection.
Plasmid 55:58–63.
Beasley, F. C., E. D. Vines, J. C. Grigg, Q. Zheng, S. Liu, G. A.
Lajoie, et al. 2009. Characterization of staphyloferrin A
biosynthetic and transport mutants in Staphylococcus aureus.
Mol. Microbiol. 72:947–963.
Beaufort, N., P. Wojciechowski, C. P. Sommerhoff, G. Szmyd,
G. Dubin, S. Eick, et al. 2008. The human fibrinolytic
system is a target for the staphylococcal metalloprotease
aureolysin. Biochem. J. 410:157–165.
Borezee-Durant, E., A. Hiron, J. C. Piard, and V. Juillard.
2009. Dual role of the oligopeptide permease Opp 3 during
growth of Staphylococcus aureus in milk. Appl. Environ.
Microbiol. 75:3355–3357.
Brogden, K. A. 2005. Antimicrobial peptides: pore formers
or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.
3:238–250.
Bubeck Wardenburg, J., T. Bae, M. Otto, F. R. Deleo, and O.
Schneewind. 2007. Poring over pores: alpha-hemolysin and
Panton-Valentine leukocidin in Staphylococcus aureus
pneumonia. Nat. Med. 13:1405–1406.
Bunce, C., L. Wheeler, G. Reed, J. Musser, and N. Barg. 1992.
Murine model of cutaneous infection with Gram-positive
cocci. Infect. Immun. 60:2636–2640.

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

S. L. Kolar et al.

Burlak, C., C. H. Hammer, M. A. Robinson, A. R. Whitney,
M. J. McGavin, B. N. Kreiswirth, et al. 2007. Global analysis
of community-associated methicillin-resistant Staphylococcus
aureus exoproteins reveals molecules produced in vitro and
during infection. Cell. Microbiol. 9:1172–1190.
Calander, A. M., I. M. Jonsson, A. Kanth, S. Arvidsson, L.
Shaw, S. J. Foster, et al. 2004. Impact of staphylococcal
protease expression on the outcome of infectious arthritis.
Microbes Infect. 6:202–206.
Calander, A. M., G. Dubin, J. Potempa, and A. Tarkowski.
2008. Staphylococcus aureus infection triggers production of
neutralizing, V8 protease-specific antibodies. FEMS
Immunol. Med. Microbiol. 52:267–272.
Camargo, I. L., and M. S. Gilmore. 2008. Staphylococcus
aureus–probing for host weakness? J. Bacteriol. 190:
2253–2256.
Carroll, R. K., T. M. Robison, F. E. Rivera, J. E. Davenport, I.
M. Jonsson, D. Florczyk, et al. 2012. Identification of an
intracellular M17 family leucine aminopeptidase that is
required for virulence in Staphylococcus aureus. Microbes
Infect. 14:989–999.
Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H.
Basma, A. Norrby-Teglund, et al. 2000. Genetic relatedness
and superantigen expression in group A streptococcus
serotype M1 isolates from patients with severe and
nonsevere invasive diseases. Infect. Immun. 68:3523–3534.
Coulter, S. N., W. R. Schwan, E. Y. Ng, M. H. Langhorne, H.
D. Ritchie, S. Westbrock-Wadman, et al. 1998.
Staphylococcus aureus genetic loci impacting growth and
survival in multiple infection environments. Mol. Microbiol.
30:393–404.
D’Agata, E. M., G. F. Webb, M. A. Horn, R. C. Jr Moellering,
and S. Ruan. 2009. Modeling the invasion of communityacquired methicillin-resistant Staphylococcus aureus into
hospitals. Clin. Infect. Dis. 48:274–284.
Diep, B. A., and M. Otto. 2008. The role of virulence
determinants in community-associated MRSA pathogenesis.
Trends Microbiol. 16:361–369.
Dumont, A. L., T. K. Nygaard, R. L. Watkins, A. Smith, L.
Kozhaya, B. N. Kreiswirth, et al. 2011. Characterization of a
new cytotoxin that contributes to Staphylococcus aureus
pathogenesis. Mol. Microbiol. 79:814–825.
Garnier, F., A. Tristan, B. Francois, J. Etienne, M. DelageCorre, C. Martin, et al. 2006. Pneumonia and new
methicillin-resistant Staphylococcus aureus clone. Emerg.
Infect. Dis. 12:498–500.
Gatlin, C. L., R. Pieper, S. T. Huang, E. Mongodin, E.
Gebregeorgis, P. P. Parmar, et al. 2006. Proteomic profiling
of cell envelope-associated proteins from Staphylococcus
aureus. Proteomics 6:1530–1549.
Gonzalez, D. J., C. Y. Okumura, A. Hollands, R. Kersten, K.
Akong-Moore, M. A. Pence, et al. 2012. Novel phenolsoluble modulin derivatives in community-associated
methicillin-resistant Staphylococcus aureus identified through

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

Proteases and Virulence

imaging mass spectrometry. J. Biol. Chem. 287:
13889–13898.
Hiron, A., E. Borezee-Durant, J. C. Piard, and V. Juillard.
2007. Only one of four oligopeptide transport systems
mediates nitrogen nutrition in Staphylococcus aureus.
J. Bacteriol. 189:5119–5129.
Holtfreter, S., T. T. Nguyen, H. Wertheim, L. Steil, H. Kusch,
Q. P. Truong, et al. 2009. Human immune proteome in
experimental colonization with Staphylococcus aureus. Clin.
Vaccine Immunol. 16:1607–1614.
Imamura, T., S. Tanase, G. Szmyd, A. Kozik, J. Travis, and
J. Potempa. 2005. Induction of vascular leakage through
release of bradykinin and a novel kinin by cysteine
proteinases from Staphylococcus aureus. J. Exp. Med.
201:1669–1676.
Johnson, J. K., T. Khoie, S. Shurland, K. Kreisel, O. C. Stine,
and M. C. Roghmann. 2007. Skin and soft tissue infections
caused by methicillin-resistant Staphylococcus aureus USA300
clone. Emerg. Infect. Dis. 13:1195–1200.
Kansal, R. G., A. McGeer, D. E. Low, A. Norrby-Teglund, and
M. Kotb. 2000. Inverse relation between disease severity and
expression of the streptococcal cysteine protease, SpeB,
among clonal M1T1 isolates recovered from invasive
group A streptococcal infection cases. Infect. Immun.
68:6362–6369.
Kansal, R. G., V. Nizet, A. Jeng, W. J. Chuang, and M. Kotb.
2003. Selective modulation of superantigen-induced
responses by streptococcal cysteine protease. J. Infect. Dis.
187:398–407.
Karlsson, A., and S. Arvidson. 2002. Variation in extracellular
protease production among clinical isolates of Staphylococcus
aureus due to different levels of expression of the protease
repressor sarA. Infect. Immun. 70:4239–4246.
Karlsson, A., P. Saravia-Otten, K. Tegmark, E. Morfeldt, and S.
Arvidson. 2001. Decreased amounts of cell wall-associated
protein A and fibronectin-binding proteins in Staphylococcus
aureus sarA mutants due to up-regulation of extracellular
proteases. Infect. Immun. 69:4742–4748.
Kavanaugh, J. S., M. Thoendel, and A. R. Horswill. 2007. A
role for type I signal peptidase in Staphylococcus aureus
quorum sensing. Mol. Microbiol. 65:780–798.
Kobayashi, S. D., and F. R. DeLeo. 2009. An update on
community-associated MRSA virulence. Curr. Opin.
Pharmacol. 9:545–551.
Kolar, S. L., V. Nagarajan, A. Oszmiana, F. E. Rivera, H. K.
Miller, J. E. Davenport, et al. 2011. NsaRS is a cellenvelope-stress-sensing two-component system of
Staphylococcus aureus. Microbiology 157:2206–2219.
Koprivnjak, T., V. Mlakar, L. Swanson, B. Fournier, A.
Peschel, and J. P. Weiss. 2006. Cation-induced
transcriptional regulation of the dlt operon of Staphylococcus
aureus. J. Bacteriol. 188:3622–3630.
Kubica, M., K. Guzik, J. Koziel, M. Zarebski, W. Richter, B.
Gajkowska, et al. 2008. A potential new pathway for

31

Proteases and Virulence

Staphylococcus aureus dissemination: the silent survival of S.
aureus phagocytosed by human monocyte-derived
macrophages. PLoS ONE 3:e1409.
Laarman, A. J., M. Ruyken, C. L. Malone, J. A. van Strijp,
A. R. Horswill, and S. H. Rooijakkers. 2011.
Staphylococcus aureus metalloprotease aureolysin cleaves
complement C3 to mediate immune evasion. J. Immunol.
186:6445–6453.
Laarman, A. J., G. Mijnheer, J. M. Mootz, W. J. van Rooijen,
M. Ruyken, C. L. Malone, et al. 2012. Staphylococcus aureus
Staphopain A inhibits CXCR2-dependent neutrophil
activation and chemotaxis. EMBO J. doi:10.1038/emboj.
2012.212.
Labandeira-Rey, M., F. Couzon, S. Boisset, E. L. Brown,
M. Bes, Y. Benito, et al. 2007. Staphylococcus aureus PantonValentine leukocidin causes necrotizing pneumonia. Science
315:1130–1133.
Li, M., B. A. Diep, A. E. Villaruz, K. R. Braughton, X. Jiang,
F. R. DeLeo, et al. 2009. Evolution of virulence in epidemic
community-associated methicillin-resistant Staphylococcus
aureus. Proc. Natl. Acad. Sci. USA 106:5883–5888.
Limbago, B., G. E. Fosheim, V. Schoonover, C. E. Crane,
J. Nadle, S. Petit, et al. 2009. Characterization of
methicillin-resistant Staphylococcus aureus isolates collected
in 2005 and 2006 from patients with invasive disease: a
population-based analysis. J. Clin. Microbiol. 47:1344–1351.
Lindsay, J. A., and S. J. Foster. 1999. Interactive regulatory
pathways control virulence determinant production and
stability in response to environmental conditions in
Staphylococcus aureus. Mol. Gen. Genet. 262:323–331.
Liu, M., J. R. Bayjanov, B. Renckens, A. Nauta, and
R. J. Siezen. 2010. The proteolytic system of lactic acid
bacteria revisited: a genomic comparison. BMC Genomics
11:36.
Loffler, B., M. Hussain, M. Grundmeier, M. Bruck,
D. Holzinger, G. Varga, et al. 2010. Staphylococcus aureus
panton-valentine leukocidin is a very potent cytotoxic factor
for human neutrophils. PLoS Pathog. 6:e1000715.
Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J.
Med. 339:520–532.
Massimi, I., E. Park, K. Rice, W. Muller-Esterl, D. Sauder, and
M. J. McGavin. 2002. Identification of a novel maturation
mechanism and restricted substrate specificity for the SspB
cysteine protease of Staphylococcus aureus. J. Biol. Chem.
277:41770–41777.
McAdow, M., H. K. Kim, A. C. Dedent, A. P. Hendrickx,
O. Schneewind, and D. M. Missiakas. 2011. Preventing
Staphylococcus aureus sepsis through the inhibition of its
agglutination in blood. PLoS Pathog. 7:e1002307.
McAleese, F. M., E. J. Walsh, M. Sieprawska, J. Potempa, and
T. J. Foster. 2001. Loss of clumping factor B fibrinogen
binding activity by Staphylococcus aureus involves cessation
of transcription, shedding and cleavage by metalloprotease.
J. Biol. Chem. 276:29969–29978.

32

S. L. Kolar et al.

McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram,
S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel
electrophoresis typing of oxacillin-resistant Staphylococcus
aureus isolates from the United States: establishing a
national database. J. Clin. Microbiol. 41:5113–5120.
McGavin, M. J., C. Zahradka, K. Rice, and J. E. Scott. 1997.
Modification of the Staphylococcus aureus fibronectin
binding phenotype by V8 protease. Infect. Immun. 65:
2621–2628.
Miller, H. K., R. K. Carroll, W. N. Burda, C. N. Krute,
J. E. Davenport, and L. N. Shaw. 2012. The
Extracytoplasmic Function Sigma Factor sigmaS
Protects against both Intracellular and Extracytoplasmic
Stresses in Staphylococcus aureus. J. Bacteriol. 194:
4342–4354.
Montgomery, C. P., S. Boyle-Vavra, P. V. Adem, J. C. Lee,
A. N. Husain, J. Clasen, et al. 2008. Comparison of
virulence in community-associated methicillin-resistant
Staphylococcus aureus pulsotypes USA300 and USA400 in a
rat model of pneumonia. J. Infect. Dis. 198:561–570.
Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim,
L. K. McDougal, R. B. Carey, et al. 2006. Methicillinresistant S. aureus infections among patients in the
emergency department. N. Engl. J. Med. 355:666–674.
Morgan, M. 2005. Staphylococcus aureus, Panton-Valentine
leukocidin, and necrotising pneumonia. BMJ 331:
793–794.
Morinaga, N., Y. Kaihou, and M. Noda. 2003. Purification,
cloning and characterization of variant LukE-LukD with
strong leukocidal activity of staphylococcal bi-component
leukotoxin family. Microbiol. Immunol. 47:81–90.
Novick, R. P. 2006. Staphylococcal Pathogenesis and
Pathogenicity Factors: Genetics and regulation. Pp. 496–516
in V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy
and J. I. Rood, eds. Gram-positive pathogens. ASM Press,
Washington, DC.
Oogai, Y., M. Matsuo, M. Hashimoto, F. Kato, M. Sugai, and
H. Komatsuzawa. 2011. Expression of virulence factors by
Staphylococcus aureus grown in serum. Appl. Environ.
Microbiol. 77:8097–8105.
Popovich, K. J., R. A. Weinstein, and B. Hota. 2008. Are
community-associated methicillin-resistant Staphylococcus
aureus (MRSA) strains replacing traditional nosocomial
MRSA strains? Clin. Infect. Dis. 46:787–794.
Potempa, J., W. Watorek, and J. Travis. 1986. The inactivation
of human plasma alpha 1-proteinase inhibitor by
proteinases from Staphylococcus aureus. J. Biol. Chem.
261:14330–14334.
Potempa, J., A. Dubin, G. Korzus, and J. Travis. 1988.
Degradation of elastin by a cysteine proteinase from
Staphylococcus aureus. J. Biol. Chem. 263:2664–2667.
Prajsnar, T. K., V. T. Cunliffe, S. J. Foster, and S. A. Renshaw.
2008. A novel vertebrate model of Staphylococcus aureus
infection reveals phagocyte-dependent resistance of zebrafish

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

S. L. Kolar et al.

to non-host specialized pathogens. Cell. Microbiol. 10:
2312–2325.
Prokesova, L., B. Potuznikova, J. Potempa, J. Zikan, J. Radl, L.
Hachova, et al. 1992. Cleavage of human immunoglobulins
by serine proteinase from Staphylococcus aureus. Immunol.
Lett. 31:259–265.
Reed, S. B., C. A. Wesson, L. E. Liou, W. R. Trumble, P. M.
Schlievert, G. A. Bohach, et al. 2001. Molecular
characterization of a novel Staphylococcus aureus serine
protease operon. Infect. Immun. 69:1521–1527.
Rice, K., R. Peralta, D. Bast, J. de Azavedo, and M. J.
McGavin. 2001. Description of staphylococcus serine
protease (ssp) operon in Staphylococcus aureus and nonpolar
inactivation of sspA-encoded serine protease. Infect. Immun.
69:159–169.
Rivera, F. E., H. K. Miller, S. L. Kolar, S. M. Jr Stevens, and
L. N. Shaw. 2012. The impact of CodY on virulence
determinant production in community-associated
methicillin-resistant Staphylococcus aureus. Proteomics
12:263–268.
Shaw, L., E. Golonka, J. Potempa, and S. J. Foster. 2004. The
role and regulation of the extracellular proteases of
Staphylococcus aureus. Microbiology 150:217–228.
Shaw, L. N., C. Lindholm, T. K. Prajsnar, H. K. Miller, M. C.
Brown, E. Golonka, et al. 2008. Identification and
characterization of sigmaS, a novel component of the
Staphylococcus aureus stress and virulence responses. PLoS
ONE 3:e3844.
Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M.
Puklo, B. Lupa, et al. 2004. Degradation of human
antimicrobial peptide LL-37 by Staphylococcus aureusderived proteinases. Antimicrob. Agents Chemother.
48:4673–4679.
Siezen, R. J. 1999. Multi-domain, cell-envelope proteinases of
lactic acid bacteria. Antonie Van Leeuwenhoek 76:139–155.
Sifri, C. D., J. Begun, F. M. Ausubel, and S. B. Calderwood. 2003.
Caenorhabditis elegans as a model host for Staphylococcus
aureus pathogenesis. Infect. Immun. 71:2208–2217.
Smagur, J., K. Guzik, M. Bzowska, M. Kuzak, M. Zarebski,
T. Kantyka, et al. 2009a. Staphylococcal cysteine protease
staphopain B (SspB) induces rapid engulfment of human
neutrophils and monocytes by macrophages. Biol. Chem.
390:361–371.
Smagur, J., K. Guzik, L. Magiera, M. Bzowska, M. Gruca, I. B.
Thogersen, et al. 2009b. A new pathway of staphylococcal
pathogenesis: apoptosis-like death induced by Staphopain B
in human neutrophils and monocytes. J. Innate Immun.
1:98–108.
Tenover, F. C., S. McAllister, G. Fosheim, L. K. McDougal, R.
B. Carey, B. Limbago, et al. 2008. Characterization of
Staphylococcus aureus isolates from nasal cultures collected
from individuals in the United States in 2001 to 2004. J.
Clin. Microbiol. 46:2837–2841.

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

Proteases and Virulence

Thurlow, L. R., G. S. Joshi, and A. R. Richardson. 2012. Virulence
strategies of the dominant USA300 lineage of communityassociated methicillin-resistant Staphylococcus aureus
(CA-MRSA). FEMS Immunol. Med. Microbiol. 65:5–22.
Travis, J., J. Potempa, and H. Maeda. 1995. Are bacterial
proteinases pathogenic factors? Trends Microbiol. 3:405–407.
Voyich, J. M., M. Otto, B. Mathema, K. R. Braughton,
A. R. Whitney, D. Welty, et al. 2006. Is Panton-Valentine
leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease?
J. Infect. Dis. 194:1761–1770.
Wang, R., K. R. Braughton, D. Kretschmer, T. H. Bach, S. Y.
Queck, M. Li, et al. 2007. Identification of novel cytolytic
peptides as key virulence determinants for communityassociated MRSA. Nat. Med. 13:1510–1514.
Webb, G. F., M. A. Horn, E. M. D’Agata, R. C. Moellering,
and S. Ruan. 2009. Competition of hospital-acquired and
community-acquired methicillin-resistant Staphylococcus
aureus strains in hospitals. J. Biol. Dyn. 48:271.
Wegrzynowicz, Z., P. B. Heczko, G. R. Drapeau, J. Jeljaszewicz,
and G. Pulverer. 1980. Prothrombin activation by a
metalloprotease from Staphylococcus aureus. J. Clin.
Microbiol. 12:138–139.
Wiltshire, M. D., and S. J. Foster. 2001. Identification and
analysis of Staphylococcus aureus components expressed by
a model system of growth in serum. Infect. Immun. 69:
5198–5202.
Wormann, M. E., N. T. Reichmann, C. L. Malone, A. R.
Horswill, and A. Grundling. 2011. Proteolytic cleavage
inactivates the Staphylococcus aureus lipoteichoic acid
synthase. J. Bacteriol. 193:5279–5291.
Zielinska, A. K., K. E. Beenken, H. S. Joo, L. N. Mrak, L. M.
Griffin, T. T. Luong, et al. 2011. Defining the straindependent impact of the Staphylococcal accessory regulator
(sarA) on the alpha-toxin phenotype of Staphylococcus
aureus. J. Bacteriol. 193:2948–2958.

Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Gelatin zymography of the LAC wild-type and
its protease-null mutant.
Figure S2. Exoprotease deletion does not lead to observable difference in agr or hla transcript levels.
Figure S3. Western blot analysis confirms increased abundance of select surface and secreted virulence factors upon
exo-protease deletion.
Figure S4. Exoprotease deletion leads to increased a-hemolysin
activity.
Figure S5. Secreted proteolytic activity of clinical S. aureus isolates.

33

Proteases and Virulence

Table S1. Collective alterations in protein abundance for
secreted proteins upon deletion of extracellular proteases
in S. aureus USA300.
Table S2. Individual fraction analysis of alterations in
protein stability for secreted proteins upon deletion of
extracellular proteases in S. aureus USA300.

34

S. L. Kolar et al.

Table S3. Collective alterations in protein abundance for
surface proteins upon deletion of extracellular proteases
in S. aureus USA300.
Table S4. Individual fraction analysis of alterations in
protein stability for surface proteins upon deletion of
extracellular proteases in S. aureus USA300.

ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd.

